Related Experiment Video

Updated: Mar 20, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K

TMPyP4 promotes cancer cell migration at low doses, but induces cell death at high doses

Xiao-Hui Zheng1,2,3, Xin Nie2,3, Hai-Ying Liu2,3

  • 1Medical School, Shenzhen University, Shenzhen 518060, P. R. China.

Scientific Reports
|May 26, 2016
PubMed

Insights

Tetrapyrrole macrocycle TMPyP4 shows dual effects in cancer therapy. Low doses promote tumor cell migration, while high doses inhibit proliferation and induce cell death, suggesting higher doses for therapeutic use.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Tetrapyrrole macrocycle TMPyP4 is investigated for photodynamic therapy and G-quadruplex stabilization in cancer treatment.
  • The comprehensive biological effects and potential adverse effects of TMPyP4 remain incompletely understood.

Purpose of the Study:

  • To investigate the gene expression alterations induced by TMPyP4 using whole genome RNA-seq.
  • To elucidate the impact of TMPyP4 on cellular processes, particularly cell adhesion and migration.

Main Methods:

  • Whole genome RNA-sequencing (RNA-seq) to analyze gene expression changes.
  • Cell adhesion assays, scratch-wound assays, and Transwell assays to evaluate cell migration and proliferation.

Main Results:

  • TMPyP4 significantly alters gene expression, with 27.67% of changed genes related to cell adhesion.
  • Low doses (≤0.5 μM) of TMPyP4 enhance cell-matrix adhesion and promote tumor cell migration.
  • High doses (≥2 μM) of TMPyP4 inhibit cell proliferation and induce cell death.

Conclusions:

  • TMPyP4 exhibits dose-dependent effects on cancer cells, influencing both migration and viability.
  • The promotion of cell migration at lower doses suggests a potential complication or a strategy for therapeutic application.
  • Higher doses of TMPyP4 are indicated for therapeutic purposes due to their antiproliferative and cell-death-inducing effects, offering new insights into TMPyP4-based cancer therapy.

More Related Videos

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System09:55

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

Published on: December 20, 2021

3.5K
Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

11.7K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.1K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K